Litigation Details for Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2016)
✉ Email this page to a colleague
Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-11-30 |
Court | District Court, D. Delaware | Date Terminated | 2020-01-21 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | Defendant | Referred To | |
Parties | ALLERGAN SALES LLC; TEVA PHARMACEUTICALS USA, INC. | ||
Patents | 6,660,715; 6,858,650; 7,041,786; 7,304,036; 7,371,727; 7,384,980; 7,476,652; 7,704,947; 7,713,930; 7,745,409; 7,771,707; 7,855,230; 7,985,772; 8,080,526; 8,110,553; 8,338,478; 8,449,909; 8,557,291; 8,618,049; 8,679,069; 8,748,573; 8,758,813; 8,802,628; 8,822,438; 8,933,030; 8,992,486; 9,044,398; 9,248,195; 9,285,372; 9,339,507; 9,358,240; 9,526,844; 9,592,200; 9,604,008; 9,708,371; 9,763,883; RE38,551; RE44,186 | ||
Attorneys | Lauren M. Lesko; Samuel S. Park | ||
Firms | Devlin Law Firm; Morris, Nichols, Arsht & Tunnell | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc.
Biologic Drugs cited in Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2018-05-09 | 169 | Patent/Trademark Report to Commissioner | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,708,371 B2 . (Vrana, Robert…2016 21 January 2020 1:16-cv-01114 830 Patent Defendant District Court, D. Delaware | External link to document |
2018-06-12 | 183 | Stipulation to EXTEND Time | Discovery, including ESI, with repsect to U.S. Patent No. 9,708,371 and MPI's ANDA to June 27, 2018 - filed …2016 21 January 2020 1:16-cv-01114 830 Patent Defendant District Court, D. Delaware | External link to document |
2018-06-26 | 191 | Stipulation to EXTEND Time | Standard for Discovery with Respect to U.S. Patent No. 9,708,371 and MPI's ANDA to July 5, 2018 - filed by…2016 21 January 2020 1:16-cv-01114 830 Patent Defendant District Court, D. Delaware | External link to document |
2018-07-10 | 214 | Motion to Dismiss/Lack of Subject Jurisdiction | MOTION to Dismiss with respect to U.S. Patent No. 9,708,371 - filed by Allergan Sales LLC, Allergan …2016 21 January 2020 1:16-cv-01114 830 Patent Defendant District Court, D. Delaware | External link to document |
2018-07-10 | 215 | Opening Brief in Support | BRIEF in Support re 214 MOTION to Dismiss the 9,708,371 Patent, filed by Allergan Sales LLC, Allergan USA…2016 21 January 2020 1:16-cv-01114 830 Patent Defendant District Court, D. Delaware | External link to document |
2018-08-15 | 241 | Stipulation of Dismissal | -captioned actions with respect to U.S. Patent No. 8,933,030, as between Plaintiffs and Sandoz, are hereby…2016 21 January 2020 1:16-cv-01114 830 Patent Defendant District Court, D. Delaware | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |